Telemetry Investments, L.L.C. Adma Biologics, Inc. Transaction History

Telemetry Investments, L.L.C.

$63.3 Million
Q4 2022

A detailed history of Telemetry Investments, L.L.C. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Telemetry Investments, L.L.C. holds 57,500 shares of ADMA stock, worth $1.16 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

57,500

Previous 72,500 20.69%

Holding current value

$1.16 Million

Previous $176,000 26.7%

% of portfolio

0.35%

Previous 0.23%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.47 - $3.88 $37,050 - $58,200	-15,000 Reduced 20.69%	57,500 $223,000
Q3 2022 Nov 17, 2022	SELL	$2.03 - $2.86 $55,824 - $78,650	-27,500 Reduced 27.5%	72,500 $176,000
Q2 2022 Aug 15, 2022	SELL	$1.43 - $2.2 $189,475 - $291,500	-132,500 Reduced 56.99%	100,000 $198,000
Q1 2022 May 16, 2022	SELL	$1.28 - $1.83 $35,200 - $50,325	-27,500 Reduced 10.58%	232,500 $425,000
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.66 $218,000 - $332,000	200,000 Added 333.33%	260,000 $367,000
Q3 2021 Nov 15, 2021	BUY	$1.13 - $1.65 $67,800 - $99,000	60,000 New	60,000 $68,000
Q1 2021 May 17, 2021	SELL	$1.67 - $2.95 $335,027 - $591,814	-200,615 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.8 - $2.56 $7,200 - $10,240	4,000 Added 2.03%	200,615 $391,000
Q3 2020 Nov 16, 2020	SELL	$2.04 - $3.74 $170,393 - $312,387	-83,526 Reduced 29.82%	196,615 $470,000
Q2 2020 Aug 14, 2020	SELL	$2.42 - $3.29 $25,700 - $34,939	-10,620 Reduced 3.65%	280,141 $821,000
Q1 2020 May 15, 2020	BUY	$1.5 - $4.59 $208,141 - $636,912	138,761 Added 91.29%	290,761 $837,000
Q4 2019 Feb 14, 2020	BUY	$3.89 - $5.15 $342,320 - $453,200	88,000 Added 137.5%	152,000 $608,000
Q3 2019 Nov 14, 2019	SELL	$3.19 - $5.39 $149,945 - $253,356	-47,005 Reduced 42.34%	64,000 $285,000
Q2 2019 Aug 14, 2019	BUY	$3.52 - $5.24 $390,737 - $581,666	111,005 New	111,005 $430,000

Others Institutions Holding ADMA

# of Institutions

315

Shares Held

184M

Call Options Held

864K

Put Options Held

91.6K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.97B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Telemetry Investments, L.L.C. with notifications on news.

Account

Telemetry Investments, L.L.C. Adma Biologics, Inc. Transaction History